ALNYLAM PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 6561000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2010-09-30) |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:48.525796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4ff23e96-0da1-4745-88d0-e03362234346
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950123-10-101051Retrieved: 2026-08-19T11:51:48.525796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/accounts-payable/2010-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4ff23e96-0da1-4745-88d0-e03362234346
History
- no predecessors — first report